The app, called Drugs@FDA Express, is a slimmed down version of the agency’s Drugs@FDA webpage. On the app, users will be able to search for information on FDA-approved brand and generic drugs and biological therapeutics. Drugs@FDA Express will also feature recent FDA product approvals from the past week, along with answers to frequently asked questions.
In a March 22 statement, FDA Commissioner Scott Gottlieb, MD, suggested convenient access to drug information through the Drugs@FDA Express app will “empower patients and providers in making their treatment decisions.”
“Advancing mobile apps that inform people about their health and medical choices represents a significant public health opportunity and is a high priority for the FDA,” he said. “The FDA is continuously seeking ways to bring information to consumers in more accessible formats.”
The app is available for download on iTunes and Google Play app stores at no cost.
More articles on supply chain:
FDA approves first frontline treatment for advanced Hodgkin lymphoma in 40 years
J&J CFO to retire in September, Joseph Wolk to take post
FDA: Philips inadequately investigated 1,000+ complaints at Ohio facility since 2016
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
